[1]
M. Peruzzi, “Comparative Risk-Benefit Analysis of Different Classes of Biologic Agents in Patients with Psoriasis: A Case Study on the Pros and Cons of Mixed Treatment Comparison in Synthesizing Complex Evidence Networks”, ijsmr, vol. 3, no. 3, pp. 231–247, Aug. 2014.